Lucas Vitale - 17 Mar 2026 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Reporting relationship: CP&BOO
Issuer ticker: OFIX
Reported as of: 17 Mar 2026
Net transaction value: -$50,886
SEC form: 4
Accepted by SEC: 19 Mar 2026, 16:31:40 UTC
Prior SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Andres Cedron, attorney-in-fact

Key filing fact

Lucas Vitale filed Form 4 for Orthofix Medical Inc. (OFIX) on 19 Mar 2026.

Key facts

This page summarizes Lucas Vitale's Form 4 filing for Orthofix Medical Inc. (OFIX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Mar 2026, 16:31.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: -$50,886.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001763869 Primary reporting owner

Vitale Lucas

Relationship: CP&BOO
Address: 3451 PLANO PARKWAY, LEWISVILLE
Signature: /s/ J. Andres Cedron, attorney-in-fact
Signature date: 19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OFIX transaction

Common Stock

Sale

Transaction value: $50,886
Shares: -4,269
Change %: -2.6%
Price: $11.92
Shares after: 160,449
Date: 17 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

Footnote F2

Includes 127,256 previously reported restricted stock units.